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Objective: By applying receiver operating characteristic curve analysis, the objective of this
study  was to see whether hemoglobin levels reﬂect body iron stores in a group of pregnant
women at term who, by using serum ferritin as the reference test, had a high pre-test prob-
ability of having iron deﬁciency anemia. Likewise, we evaluated the ability of hemoglobin
and  maternal serum ferritin levels to predict iron deﬁciency anemia in newborns.
Methods: Hemoglobin and serum ferritin were measured in 187 pregnant women at term
belonging to a group with a high pre-test probability of iron deﬁciency anemia and their
newborns. Women with Hb <11.0 g/dL and newborns with cord Hb <13.0 g/dL were classiﬁed
as anemic. A serum ferritin <12.0 g/L in women and a cord blood serum ferritin <35.0 g/L
were considered to reﬂect empty iron stores. Receiver operating characteristic curve analysis
was applied to select the cut-off points that better reﬂected iron stores.
Results: The Hb cut-off point selected by receiver operating characteristic curve analysis in
women was <11.5 g/dL (sensitivity: 60.82, speciﬁcity: 53.33%, Youden Index: 0.450). Most of
the  newborns had normal Hb which precluded this analysis. Maternal Hb <11.0 g/dL was
the cut-off point that best reﬂected iron deﬁciency anemia in newborns (sensitivity: 55.88%,
speciﬁcity: 57.24%, Youden Index: 0.217). The best cut-off point of maternal serum ferritin to
reﬂect empty iron stores in newborns was <6.0 g/L (sensitivity: 76.47%, speciﬁcity: 31.58%,
Youden Index: 0.200).
Conclusion: Hemoglobin concentration performed poorly to detect iron deﬁciency anemia in
women at term with high risk for iron deﬁciency and their newborns.© 2015 Associac¸ão Bra
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Nuevo  León, Mexico.
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eceiver operating characteristic (ROC) curve analysis is
sed to evaluate the diagnostic performance of a test.1 The
OC curve provides accurate information about the trade-off
etween the two most important aspects of diagnostic per-
ormance: sensitivity (the probability that a test result will
e positive when the disease is present) and speciﬁcity (the
robability that a test result will be negative when the dis-
ase is not present).1 In addition, the area under the ROC plot
an be expressed as a quantitative index, A(z), that summa-
izes the diagnostic performance described by the entire ROC
urve. The value of the A(z) index varies from 0.5 (no apparent
ccuracy, the ROC curve will coincide with the diagonal) to 1.0
perfect accuracy).2
Iron-deﬁciency (ID) anemia is the most common nutri-
ional disorder in the world. At least 2 billion people, that
s, over 30% of the world’s population are anemic, many  due
o ID.3 The prevalence of ID anemia is remarkably high in
regnant women, because of the increase of iron requirements
uring the second and third trimesters with the expansion of
aternal blood volume and fetal red cell mass.4 This disease
articularly affects pregnant women and infants in developing
ountries.5 Although there is strong evidence demonstrating
hat the acquisition of iron by the fetus is limited by the pres-
nce of ID in the mother,6 numerous studies have shown that
he fetus can accumulate enough iron despite mild to moder-
te maternal ID.7
The most commonly used test to screen for ID is the
emoglobin (Hb) concentration, which reﬂects the amount of
unctional iron in the body. Although it is a late indicator of
D, the level of Hb is essential for the diagnosis of ID anemia.8
he Centers for Disease Control and Prevention (CDC) deﬁne
estational anemia during the third trimester of pregnancy as
 Hb level <11.0 g/dL at sea level9 and a level of serum ferritin
SF) <12.0 mg/L is considered to be the gold standard for the
iagnosis of ID in pregnant women.9
Iron is transferred to the fetus through the placenta
gainst a concentration gradient, particularly during the later
tages of pregnancy, with the amount of iron transported
cross the placenta increasing as pregnancy progresses.4
everal factors inﬂuence the concentration of Hb at birth,
ncluding gestational age, gender, state of maternal iron
eserves, and other factors affecting the maternal-fetal iron
xchange.
In term pregnancies, 70–80% of fetal iron is present in the
ed cells as Hb.4 Anemia in newborns is established with a
ord blood Hb concentration <13.0 g/dL.5 The cutoff cord blood
erum ferritin (CSF) indicating iron deﬁciency in the newborn
s set at <35.0 mg/L at which point the iron available to meet
ormal brain requirements is restricted.4 SF is, in addition
o the direct examination of stainable iron in bone-marrow
mears, the most speciﬁc indicator of body iron reserves.10 By
sing SF as the reference test and applying ROC curve analysis,
he objective of this study was to determine whether Hb levels
eﬂect the body iron stores in a group of pregnant women at
erm with a high pre-test probability of having ID. Likewise,
he usefulness of maternal Hb and SF levels to predict ID in
ewborns was evaluated. 1 5;3  7(3):178–183 179
Methods
One hundred and eighty-seven pregnant women at term
of normal pregnancies and their newborns attended at the
Hospital Universitario Dr. José E. González of the Universi-
dad Autónoma de Nuevo León, Monterrey, AC, Mexico, were
enrolled in this study. Informed consent was obtained from
all mothers and the principles of the Declaration of Helsinki
were followed. All of the women had a single pregnancy, were
uninsured and belonged to the low-income urban population
of Monterrey, Mexico, (altitude: 524 meters above sea level).
Women  with comorbidities, including diabetes and infections,
were excluded.
Samples of blood for Hb and SF measurement were
obtained from the mother and the newborn’s cord. The Hb
concentration was determined in an automated blood cell
counter. Women with a value lower than 11.0 g/dL were clas-
siﬁed as anemic.7 Newborns with cord Hb value <13.0 g/dL
were also classiﬁed as anemic.5 After being separated by
centrifugation, serum was stored at −20 ◦C and the SF con-
centration was measured in duplicate within two weeks of
collection by an enzyme-linked immunosorbent assay (Fer-
rizyme, Abbott Laboratories, North Chicago, IL) based on a
previously described modiﬁcation of a method.11 A value
lower than 12.0 mg/L of SF is considered to reﬂect empty
iron stores in pregnant women at term;12 in newborns the
cutoff for CSF of severe ID is <35.0 mg/L.4 No other red
blood cell index or iron saturation data are included in this
report.
The statistical evaluation was performed using ROC curve
analysis1,2 employing MedCalc Statistical Software (version
14.8.1). The diagnostic properties of the tests were calculated
based on the predictive value model.13,14
Results
A total of 77 (41.4%) pregnant women were anemic at term (Hb
<11.0 g/dL) and 171 (91.9%) were ID (SF <12.0 mg/L). The mean
Hb concentration in the study group was 11.11 ± 1.57 g/dL
(range: 6.50–14.90 g/dL), whereas the mean SF value was
5.78 ± 7.20 mg/L (range: 0.0–50.0 mg/L).
Figure 1 shows the graph generated by ROC analysis. An
Hb concentration <11.5 g/dL was found to be the best cutoff
point to reﬂect empty iron stores based on a ferritin value
<12.0 mg/L. The sensitivity of the Hb level at this value was
60.82% with a speciﬁcity of 53.33%. The diagnostic power of Hb,
expressed as the area under the ROC curve (AUC), was 0.656,
with a 95% conﬁdence interval of 0.583–0.7244. The Youden
index of Hb concentration to reﬂect corporal iron stores in the
study group, as evaluated by SF, was 0.450. The corresponding
values for different ROC-derived Hb cutoff values are shown
in Table 1.
In the group of newborns, six (3.2%)6 were anemic (Hb
<13.0 g/dL) and 34 (18.3%) were ID (CSF <35.0 mg/L). The mean
Hb concentration in the study group was 15.69 ± 1.89 g/dL
(range: 11.0–22.0 g/dL), whereas the mean CSF value was
79.30 ± 55.14 mg/L (range: 2.94–322.65 mg/L). Almost 97% of
newborns had normal Hb which precluded the application of
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Table 1 – Performance evaluation for different receiver operating characteristic curve-derived hemoglobin cutoff values in
pregnant women at term.
Maternal hemoglobin cutoff value (g/dL)
<10.8 <11.0 <11.3 <11.5a <11.7 <12.0 <14.9
Sensitivity (%) 42.7 47.4 55.6 60.8 67.8 73.1 100.0
Speciﬁcity (%) 100.0 80.0 66.7 53.3 46.7 33.3 0
Positive predictive value (%) 100.0 96.4 95.0 93.7 93.5 92.6 91.9
Negative predictive value (%) 13.3 11.8 11.6 10.7 11.3 9.8
Positive likelihood ratio 2.4 1.7 1.3 1.3 1.1 1.0
Negative likelihood ratio 0.6 0.7 0.7 0.7 0.7 0.8
a Optimal operating point chosen by ROC analysis.
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Figure 1 – Receiver operating characteristic (ROC) curve
analysis of hemoglobin (Hb) to assess iron stores in
pregnant women at term (area under the ROC curve
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Figure 2 – Receiver operating characteristic (ROC) curve
analysis of maternal hemoglobin (Hb) to assess iron stores
in newborns (area under the ROC curve [AUC]) = 0.591.
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Figure 3 – Receiver operating characteristic (ROC) curve[AUC]) = 0.656.
ROC analysis to assess its efﬁciency in respect to neonate iron
stores.
A ROC curve analysis was carried out to assess the per-
formance of maternal Hb in the assessment of iron stores
in newborns based on CSF (<35.0 mg/L). The resulting graph
shows an AUC of 0.591 with a 95% conﬁdence interval of
0.517–0.662 (Figure 2). The optimal cutoff point of maternal
Hb that best reﬂected ID in newborns was <11.0 g/dL, at this
point the sensitivity was 55.88% with a speciﬁcity of 57.24%.
The Youden index for this test was 0.200. Again, it is impor-
tant to consider that only 3.2% of neonates were anemic. The
corresponding values obtained by ROC analysis for different
cutoff points of maternal Hb are shown in Table 2.
ROC curve analysis was applied to assess the performance
of maternal SF in reﬂecting iron stores in newborns based on
a value of CSF <35.0 mg/L; a graph with an AUC of 0.600 and a
95% conﬁdence interval of 0.525–0.671 was obtained (Figure 3).
The best cutoff point of maternal SF chosen to reﬂect empty
iron stores in the newborn was <6.0 mg/L, with a sensitivity of
76.47% and a speciﬁcity of 31.58%. The lack of efﬁciency was
conﬁrmed by a Youden Index of 0.217. Different cutoff points
were used and the corresponding analysis is shown in Table 3.
analysis of maternal serum ferritin (SF) to assess iron stores
in newborns (area under the ROC curve [AUC]) = 0.600.
rev bras hematol hemoter. 2 0 1 5;3  7(3):178–183 181
Table 2 – Performance evaluation for different receiver operating characteristic curve-derived maternal hemoglobin cutoff
values for iron deﬁciency in newborns.
Maternal hemoglobin cutoff value (g/dL)
<9.0 <10.0 <11.0a <12.0 <13.0
Sensitivity (%) 20.6 35.3 55.9 76.5 88.2
Speciﬁcity (%) 93.4 82.2 57.2 28.3 9.2
Positive predictive value (%) 41.2 30.8 22.6 19.3 17.9
Negative predictive value (%) 84.0 85.0 85.3 84.3 77.8
Positive likelihood ratio 3.1 2.0 1.3 1.1 1.0
Negative likelihood ratio 0.9 0.8 0.8 0.8 1.3
a Optimal operating point chosen by ROC analysis.
Table 3 – Performance evaluation for different receiver operating characteristic curve-derived maternal serum ferritin
cutoff values for iron deﬁciency in newborns.
Maternal serum ferritin cutoff value (mg/L)
<6.0a <8.0 <9.2 <10.0 <11.1 <12.5 <13.9
Sensitivity (%) 76.5 88.2 91.2 94.1 100.0 100.0 100.0
Speciﬁcity (%) 31.6 19.1 17.1 13.2 12.5 9.2 8.6
Positive predictive value (%) 20.0 19.6 19.7 19.5 20.4 19.8 19.7
Negative predictive value (%) 85.7 87.9 89.7 90.9 100.0 100.0 100.0
Positive likelihood ratio 1.1 1.1 1.1 1.1 1.1 1.1 1.1
Negative likelihood ratio 0.8 0.6 0.5 0.5 0 0 0
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iscussion
lthough its diagnostic properties are not ideal, SF was
elected as the reference test in this study to evaluate body
ron stores in pregnant women at term and their newborns.
his is the second most accurate assay after the examination
f stainable iron in the bone marrow, and the only method
hat can provide a semi-quantitative indication of the levels
f such stores; its diagnostic efﬁciency is 91% and speciﬁcity
s 100% in iron-replete individuals.12
Even though measurements such as positive or negative
redictive values are highly dependent on the prevalence of
 disease in the studied population, the sensitivity and speci-
city of a test are independent of prevalence, thus allowing the
rawing of valid conclusions of test performance when using
OC curve analysis, such as in the present study.
Hb levels were studied in a group of women  at term with a
igh pre-test probability of having empty iron stores in order
o describe the behavior of Hb levels under demanding condi-
ions and to assess whether SF should be routinely evaluated
o assess iron status in this disadvantaged group.
High prevalences of anemia and ID were found in this
ow-income, uninsured urban population of pregnant women
n Mexico. The Hb level selected by ROC curve analysis
11.5 g/dL) was higher than the 11.0 g/dL recommended for
omen during the third trimester of pregnancy.9 At this level,
he sensitivity of hemoglobin to detect empty iron stores com-
ared to SF was low (60.82%), but remarkably similar to the
ensitivity of 61% of ferritin itself (<12.0 mg/L) when compared
o stainable iron in bone marrow smears from women of repro-
uctive age. At this value however, SF speciﬁcity reached 100%
or the correct diagnosis of ID in women of reproductive age.10
aternal Hb speciﬁcity to detect empty iron stores in pregnantwomen in the present study was 53.33%, leading to a poor
overall efﬁciency in diagnosing ID as expressed by the Youden
index of 0.450.
In spite of the high prevalence of ID and anemia in the
pregnant women studied, only 45% (77/171) of ID women
were anemic (Hb <11.0 g/dL). Therefore, it is important to con-
sider the subclinical ID without anemia (SF <12.0 mg/L and Hb
>11.0 g/dL) that was presented by 55% of these women. This
shows the lack of efﬁciency of Hb to detect ID in pregnant
women belonging to populations with a high pre-test prob-
ability of ID. This is reﬂected by the low AUC of 0.656 and
the corresponding low Youden index. Our results are similar
to those obtained in a study in India,15 in which no corre-
lation between Hb and SF, as well as a high percentage of
subclinical ID, was found in pregnant women. In developing
countries such as Mexico and India there is a high prevalence
of ID in pregnant women, but due to the high cost and logistic
complexity of SF assays it is difﬁcult to extrapolate the rec-
ommendations derived from studies conducted in developed
countries to guide iron supplementation based on SF values.15
These ﬁndings highlight the need to study the efﬁciency of
other less expensive markers which could be used as a basis to
guide prophylaxis using iron with a higher level of efﬁciency,
such as additional red blood cell indexes,16 which were not
included in the current study. It is important to emphasize
that the results of similar studies in other populations vary
widely. A correlation between Hb and SF was found in a study
in African-American patients17 and a similar study carried out
in Malaysia.18 These studies concluded that the use of Hb as
a predictor of ID is an efﬁcient and low cost alternative for
countries with high prevalence of the disease and with limited
resources and thus cannot afford to measure SF. The study
conducted in African-Americans included only women with
anemia, whereas in the Malaysian report, the measurement
oter.
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of SF and Hb was conducted during early pregnancy, when
the incidence of gestational anemia is lowest, representing
both ends of the gestational ID spectrum. The current study
consisted of uninsured women at term belonging to a low
income population and at high risk of being iron-depleted
attended in a public hospital. This could help to explain the
signiﬁcant contrast between previous studies and the current
ﬁndings regarding the usefulness of Hb to assess iron stores.
In the newborn group, the comparison of Hb and CSF using
ROC curve analysis to assess ID was precluded because almost
97% of newborns had normal Hb. In the analysis conducted to
determine the usefulness of maternal Hb to assess iron stores
in newborns, the cutoff point recommended for women in the
third trimester of pregnancy (11.0 g/dL),7 lacked sensitivity and
speciﬁcity (55.88% and 57.24% respectively). The AUC (0.591)
demonstrated low diagnostic efﬁcacy of Hb as an indicator of
stored iron in neonates of women with a high prevalence of ID.
Despite the high prevalence of maternal anemia and ID
without anemia, only 3.2% of neonates were anemic, whereas
18.3% had ID (CSF <35.0 mg/L). Although it has been shown
that maternal iron stores strongly inﬂuence (although not
exclusively) iron stores in newborns,6 from our results and
those of others5,19 it can be concluded that the fetus uses
available iron in a preferential way to support erythropoiesis,
despite an inadequate maternal iron supply and empty iron
stores. This is consistent with data obtained from a study car-
ried out in China5 in which, as in the current population,
anemia and ID were common in pregnant women at term
while the percentages of newborns with both were very low.
When analyzing the efﬁciency of maternal SF to assess iron
stores in newborns, the results did not show that the test
performed well because the optimal cut-off point of mater-
nal SF identiﬁed using ROC analysis (6.0 mg/L) is under the
gold standard for the diagnosis of iron deﬁciency in pregnant
women (SF <12.0 mg/L). These results are not consistent with
other studies, which conclude that iron stores in neonates are
associated with maternal ones only if maternal iron status is
at risk.5 Our results may support the theory of Kilbride et al.19
who  suggested that the hematologic effects of empty mater-
nal iron stores are more  evident later in childhood than during
the newborn period. The analysis carried out in our popula-
tion found no correlation between Hb and maternal SF with
iron stores in newborns. Other markers of ID in infants have
been studied, such as reticulocyte hemoglobin content (CHr),
which is considered an early marker of ID due to the short
lifespan of reticulocytes (about 24 h), and unlike other markers
of ID, including SF, it has the advantage of not being inﬂu-
enced by chronic inﬂammation processes and acute infection.
This test has been shown to be a sensitive effective marker to
evaluate iron stores in newborns at term,20 as well in preterm
newborns.21
It is important to notice however, that in contrast to the
simplicity and low day-to-day variation of Hb concentration
measurement, the SF assay has a relatively higher inherent
methodological variability, with a 5% general coefﬁcient of
variation, which can increase to 15% for the same individual
22over a period of weeks. In comparison, serum iron determi-
nation of the same subject has a day-to-day overall coefﬁcient
of variation of 30%, as a consequence of its high physiological
variability.22
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In summary, the low performance indices for Hb in this
study, particularly a lack of sensitivity and low diagnostic efﬁ-
ciency, conﬁrmed its poor value in reﬂecting body iron stores
when the probability of iron depletion is high.23 The present
report also illustrates the usefulness of ROC curve analysis
applied to a common clinical laboratory test and how it can
help in deﬁning an appropriate range of values and a speciﬁc
cut-off point for a particular population.
Conclusions
There was a poor correlation between maternal Hb and SF
with iron stores in neonates, despite the high prevalence of
ID and anemia in women at term. Due to ﬁnancial and logistic
restrictions in developing countries, it is important to validate
inexpensive, sensitive markers to guide iron prophylaxis or
therapy during pregnancy.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
Acknowledgment
The authors gratefully acknowledge Dr. Neri Álvarez Villalobos
for his statistical analysis.
 e  f  e  r  e  n  c  e  s
1. Dwyer AJ. In pursuit of a piece of the ROC. Radiology.
1997;201(3):621–5.
2. Hanley JA, McNeil BJ. The meaning and use of the area under
a  receiver operating characteristic (ROC) curve. Radiology.
1982;143(1):29–36.
3. WHO.  Micronutrient deﬁciencies. Iron deﬁciency anaemia.
Available from: http://www.who.int/nutrition/topics/ida/en/
4. Siddappa AM, Rao R, Long JD, Widness JA, Georgieff MK. The
assessment of newborn iron stores at birth: a review of the
literature and standards for ferritin concentrations.
Neonatology. 2007;92(2):73–82.
5. Shao J, Lou J, Rao R, Georgieff MK, Kaciroti N, Felt BT, et al.
Maternal serum ferritin concentration is positively associated
with newborn iron stores in women with low ferritin status in
late pregnancy. J Nutr. 2012;142(11):2004–9.
6. Jaime-Pérez JC, Herrera-Garza JL, Gómez-Almaguer D.
Sub-optimal fetal iron acquisition under an iron-deﬁcient
maternal environment. Arch Med Res. 2005;36(5):598–602.
7. O’Brien KO, Zavaleta N, Abrams SA, Caulﬁeld LE. Maternal
iron status inﬂuences iron transfer to the fetus during the
third trimester of pregnancy. Am J Clin Nutr.
2003;77(4):924–30.
8. Centers for Disease Control and Prevention (CDC).
Recommendations to prevent and control iron deﬁciency in
the United States. Morb Mortal Wkly  Rep. 1998;47(RR-3):1–29.
9. Centers for Disease Control and Prevention (CDC). CDC
criteria for anemia in children and childbearing-aged women.
Morb Mortal Wkly Rep. 1989;38(22):400–4.
0. Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg P-A,
Hultén L. Screening for iron deﬁciency: an analysis based on
bone marrow examinations and serum ferritin
er. 2 0
1
1
1
1
1
1
1
1
1
2
2rev bras hematol hemot
determinations in a population sample of women. Br J
Haematol. 1993;85(4):787–98.
1. Linpisarn S, Kricka LL, Kennedy JH, Whitehead TP. Sensitive
sandwich enzyme immunoassay for serum ferritin on
microtitre plates. Ann Clin Biochem. 1981;18 Pt 1:48–53.
2. Worwood M. Ferritin in human tissues and serum. Clin
Haematol. 1982;11(2):275–307.
3. Galen RS, Gambino SR. Beyond normality. The predictive
value and efﬁciency of medical diagnosis. New York: Wiley;
1975.
4. Sanford J. Understanding laboratory test results. Med Clin
North Am.  1987;71(4):639–52.
5. Tiwari M, Kotwal J, Kotwal A, Mishra P, Dutta V, Chopra S.
Correlation of haemoglobin and red cell indices with serum
ferritin in Indian women in second and third trimester of
pregnancy. Med J Armed Forces India. 2013;69(1):31–6.
6. Asberg AE, Mikkelsen G, Aune MW, Asberg A. Empty iron
stores in children and young adults-the diagnostic accuracy
of  MCV, MCH, and MCHC. Int J Lab Hematol. 2013;14:1–7.
7. Casanova BF, Sammel MD, Macones GA. Development of a
clinical prediction rule for iron deﬁciency anemia in
2
2 1 5;3  7(3):178–183 183
pregnancy. Am J Obstet Gynecol. 2005;193(2):
460–6.
8. Hassan R, Abdullah WZ,  Nik Hussain NH. Anemia and iron
status of Malay women attending and antenatal clinic in
Kubang Kerian, Kelantan, Malaysia. Southeast Asian J Trop
Med Public Health. 2005;36(5):1304–7.
9. Kilbride J, Baker TG, Parapia LA, Khoury SA, Shuqaidef SW,
Jerwood D. Anemia during pregnancy as risk factor for
iron-deﬁciency anemia in infancy: a case–control study in
Jordan. Int J Epidemiol. 1999;28(3):461–8.
0. Torsvik IK, Markestad T, Ueland PM, Nilsen RM, Midttun O,
Bjorke Monsen AL. Evaluating iron status and the risk of
anemia in young infants using erythrocyte parameters.
Pediatr Res. 2013;73(2):214–20.
1. Lorenz L, Peter A, Poets CF, Franz AR. A review of cord blood
concentrations of iron status parameters to deﬁne reference
ranges for preterm infants. Neonatology. 2013;104(3):194–202.2. Worwood M. The laboratory assessment of iron status – an
update. Clin Chim Acta. 1997;259(1-2):3–23.
3. Verloop MC. Iron depletion without anemia: a controversial
subject. Blood. 1970;36(5):657–71.
